For research use only. Not for therapeutic Use.
FASN-IN-1 is a fatty acid synthase (FASN) inhibitor extracted from patent WO2015134790A1, compound 56[1].
| Catalog Number | I019271 |
| CAS Number | 1808260-84-5 |
| Synonyms | (2S)-N-[4-[4-(diethylsulfamoyl)phenyl]-1,3-thiazol-2-yl]-2-methylbutanamide |
| Molecular Formula | C18H25N3O3S2 |
| Purity | ≥95% |
| InChI | InChI=1S/C18H25N3O3S2/c1-5-13(4)17(22)20-18-19-16(12-25-18)14-8-10-15(11-9-14)26(23,24)21(6-2)7-3/h8-13H,5-7H2,1-4H3,(H,19,20,22)/t13-/m0/s1 |
| InChIKey | IXMQVFSSASHOGM-ZDUSSCGKSA-N |
| SMILES | CCC(C)C(=O)NC1=NC(=CS1)C2=CC=C(C=C2)S(=O)(=O)N(CC)CC |
| Reference | [1]. Nicholas D.P. Cosford, et al. Small molecule fatty acid synthase inhibitors. WO2015134790A1. |
